Construction of a genetically engineered chimeric apoprotein consisting of sequences derived from lidamycin and neocarzinostatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction of a genetically engineered chimeric apoprotein consisting of sequences derived from lidamycin and neocarzinostatin

Published:2016-01 Issue:1 Volume:27 Page:24-28
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Jiang Wenguo,Shang Boyang,Li Liang,Zhang Shenghua,Zhen Yongsu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Pharmacology and therapeutic applications of enediyne antitumor antibiotics.;Shao;Curr Mol Pharmacol,2008

2. Key interactions in neocarzinostatin, a protein of the immunoglobulin fold family.;Valerio-Lepiniec;Protein Eng,2002

3. Aponeocarzinostatin - a superior drug carrier exhibiting unusually high endurance against denaturants.;Sudhahar;Bioorg Med Chem,2006

4. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.;Maeda;Adv Drug Deliv Rev,2001

5. . Structures of in vitro evolved binding sites on neocarzinostatin scaffold reveal unanticipated evolutionary pathways.;Drevelle;J Mol Biol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics;Medicine in Drug Discovery;2023-12

2. Fundamental in Polymer-/Nanohybrid-Based Nanorobotics for Theranostics;Nanorobotics and Nanodiagnostics in Integrative Biology and Biomedicine;2022-12-16

3. Polymer-hybrid nanoparticles: Current advances in biomedical applications;Biomedicine & Pharmacotherapy;2020-11

4. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin;Oncology Reports;2018-11-02

5. Responsive polymer conjugates for drug delivery applications: recent advances in bioconjugation methodologies;Journal of Drug Targeting;2018-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3